Direct comparison shows that mRNA-based diagnostics incorporate information which cannot be learned directly from genomic mutations

BACKGROUND: Compared to the many uses of DNA-level testing in clinical oncology, development of RNA-based diagnostics has been more limited. An exception to this trend is the growing use of mRNA-based methods in early-stage breast cancer. Although DNA and mRNA are used together in breast cancer rese...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravkin, Hersh D., Givton, Ofer, Geffen, David B., Rubin, Eitan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236449/
https://www.ncbi.nlm.nih.gov/pubmed/32429832
http://dx.doi.org/10.1186/s12859-020-3512-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236449/
https://www.ncbi.nlm.nih.gov/pubmed/32429832
http://dx.doi.org/10.1186/s12859-020-3512-z

Ejemplares similares